aniracetam
Vérifier sur tripsit
Aniracetam
Vérifier sur psychonaut
Aniracetam
Vérifier sur isomerdesign
Aniracétam
Vérifier sur druglab
Aniracetam
Vérifier sur drugmap
Aniracetam
Vérifier sur wiki
Data
InChI: InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3
Synonymes: Aniracetam ,(S),BRD-K88611939-001-02-6,Q417630,NCGC00015116-02,aniracetam,NCGC00015116-06, 1-p-Anisoyl-2-pyrrolidinone, 1-(4-methoxybenzoyl)pyrrolidin-2-one, 72432-10-1,CHEBI:47943,Tocris-0867,DTXSID5045128,SDCCGSBI-0050103.P005,HMS3884C09,MFCD00153767,DSSTox_RID_80691,SBI-0050103.P004,NCGC00021402-05,1-p-Anisoyl-2-pyrrolidinone,AC-15651,SR-01000003147-6,SW199095-2,SPECTRUM1503078,A837527,s1281,Spectrum4_000761,NSC758223,BPBio1_001316,NCGC00015116-12,Ampamet,Aniracetam, >=98%,Memodrin,KS-5313,NCGC00260800-01,HMS3675P17,Tox21_110086,Draganon,Lopac-A-9950,Opera_ID_294,KBio2_006958,Aniracetamun [INN-Latin],ANIRACETAM [MI],SR-01000003147-2,SMR000038438,ANIRACETAM [INN],HB0116,Aniracetam p-Methoxybenzoyl-2-pirrolidone,BSPBio_003026,ANIRACETAM; 1-P-ANISOYL-2-PYRROLIDINONE, Sarpul,CHEMBL36994,LP00115,SR-01000003147,BCPP000399, 5L16LKN964, NCGC00015116-10,1-(4-Methoxybenzoyl)pyrrolidin-2-one,MLS000028591,A 9950,Tox21_110086_1,NINDS_000403, 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German],SR-01000003147-8,Spectrum3_001553,Aniracetamun,KBio3_002526,Aniracetam [USAN:INN:JAN],Ro-135057, Ro-13-5057,NSC 758223,NCGC00015116-03,HMS3266L08, 1-(4-Methoxybenzoyl)-2-pyrrolidinone, 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-, Aniracetam [USAN:INN:JAN],Tox21_500115, SMR000038438,BRD-K88611939-001-13-3,EU-0100115, UNII-5L16LKN964,aniracetam;p-methoxybenzoyl-2-pirrolidone,AB00053303_15,2-Pyrrolidinone, 1-(4-methoxybenzoyl)-,1-(4-methoxybenzoyl)pyrrolidin-2-one,Ro-13-3057,GTPL4133, MLS000079240,NCGC00015116-13,HMS501E05,Reset,NSC-758223,DivK1c_000403,NCGC00021402-02,1-p-anisoylpyrrolidin-2-one,NCGC00015116-04,Biomol-NT_000222, CHEBI:47943,SR-01000003147-4,HMS3657G11,1-(p-methoxybenzoyl)-2-pyrrolidinone,HMS2089O17,CAS-72432-10-1, Ro 135057,1-(4-Methoxy-benzoyl)-pyrrolidin-2-one,Spectrum5_001609,UNII-5L16LKN964,HMS3713N20,ZINC15951,Aniracetam,Pharmakon1600-01503078,KBioGR_001142,NCGC00021402-08,KBioSS_001822, CHEMBL36994,432A101,IDI1_000403,NCGC00015116-11,BA164183,DSSTox_CID_25128,ANIRACETAM [MART.],1-(4-Methoxybenzoyl)-2-pyrrolidinone #,BCP02091,HMS3411P17,1-(p-Methoxybenzoyl)-2-pyrrolidinon [German],KBio1_000403,H10883,NCGC00015116-01,AB00053303-14, Draganon,NCGC00015116-08,KBio2_004390,Lopac0_000115,D01883, Ampamet,CS-1793,Ro 13-5057,1-(4-Methoxybenzoyl)-2-pyrrolidone,1-(4-Methoxybenzoyl)-2-pyrrolidinone,BRN 4807205,KBio2_001822,Spectrum_001342,NCGC00021402-07,NCGC00021402-06,DSSTox_GSID_45128,DTXCID3025128,SCHEMBL70998,Sarpul,AB04115,MLS001201800,ANIRACETAM [USAN],5L16LKN964,HMS3260G12,AB00053303_16,MLS000079240,NCGC00015116-05,BCP9000303,NCGC00015116-07,1-anisoyl-2-pyrrolidinone,ANIRACETAM [JAN],Aniracetam (JAN/USAN/INN), ZXNRTKGTQJPIJK-UHFFFAOYSA-N,HMS2234E11,FT-0649064,DB04599,NCGC00015116-09,Ro-13-5057,1-(p-Methoxybenzoyl)-2-pyrrolidinon,NCGC00015116-10,CCG-204210, Aniracetamun [INN-Latin], Ro 13-5057,72432-10-1,AKOS005066313, 1-p-anisoylpyrrolidin-2-one,HMS2094K07,ANIRACETAM [WHO-DD],HY-10932,Ro 135057,1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one, BRN 4807205,NCGC00015116-24
Market name: aniracetam
Estimated data
Solubility: -2.387 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 67.1% (prediction based on www.mdpi.com)
